The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors

Ítems similars

• The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
  per: Vladimer Darsalia, et al.
  Publicat: (2018-02-01)
• Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke
  per: Darsalia, Vladimer, et al.
  Publicat: (2015)
• The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain: A Comparison With Glimepiride
  per: Darsalia, Vladimer, et al.
  Publicat: (2013)
• Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4
  per: Lietzau, Grazyna, et al.
  Publicat: (2016)
• Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review With Special Focus on Linagliptin and Stroke
  per: Darsalia, Vladimer, et al.
  Publicat: (2019)